It’s here. The first no-fuss once-daily GLP-1 pill for weight loss, Eli Lilly’s Foundayo, was approved by the US Food and Drug Administration on Wednesday. Loading audio narration… It’s a watershed moment for the type 2 diabetes and weight loss industry. Until now, patients taking the new class of GLP-1…